ARCHIVES

Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described

This article is from The Cancer Letter archive.

Vol. 01 No. 30 | July 25, 1975

Download PDF Visit The Full Archive

Related Articles

ONS Urges Congress To Back Anti-Tobacco Measures.

July 20, 2001

Arzerra Given Accelerated Approval For Leukemia

October 30, 2009

60-Mile Limit For Primate Facility Dropped

June 9, 1978

New Treatments And Quality of Life Study For Ovarian Cancer Described At SGO

March 26, 2004

FDA Approves Aranesp For Chemo-Induced Anemia

August 30, 2002

Oncologists Tell Congress Community Cancer Practices Are Not Adequately Reimbursed

April 4, 2014